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Acting Opioid (LAO) medication for chronic pain management.
The LAOs considered were transdermal fentanyl (TF), controlled
release morphine sulfate (CRMS) and controlled release oxy-
codone (CRO). METHODS: Medicaid beneﬁciaries from three
states during 1999–2000 were studied. Patients were followed
for at least one year, starting with their ﬁrst LAO prescription in
1999. Patients who did not have a LAO in the six months prior
to that index date were labeled “incident”, while patients with
a history of LAO use were labeled as “prevalent”. Patients were
then grouped by the opioid they received on the index date.
Disease-type, demographics, health status, health care utiliza-
tion, and expenditures were measured and compared among the
three LAO cohorts. LAO costs and total annual health care
expenditures by LAO cohort were compared using descriptive
and multivariate analyses, for the incident and prevalent patient
samples. RESULTS: Descriptive results indicate that incident (I)
and prevalent (P) LOA annual cost for CRO ($1361 I; $4146 P)
were signiﬁcantly higher than costs observed for TF ($1202 I;
$3061 P) or CRMS ($919 I; $3572 P) (p < 0.01). After control-
ling for confounding characteristics, total annual health expen-
ditures in the CRO incidence sample were similar to the CRMS
sample. However, total annual health care expenditures for the
CRO population were signiﬁcantly lower than expenditures for
the TF population, with an annual cost savings of about $960
(p < 0.01). Economic differences were not noted among the
prevalent LAO populations. CONCLUSIONS: Total cost, not
just pharmaceutical costs, should be considered when making
policy decisions about insurance coverage for LAO drugs. In the
incident sample, patients on TF cost about $960 more per year
(p < 0.01), on average, compared to similar CRMS and CRO
patients.
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OBJECTIVES: The number of patients on opiates for chronic
non-malignant pain continues to grow. With an emphasis on
treating pain, opiate medication is being used more often. Fol-
lowing patients in a Primary care clinic has become more difﬁ-
cult because of the increased time required to manage and assess
medication effects and the large number of unscheduled walk-in
visits. Our objectives were to reduce unscheduled walk-in visits,
reduce substance abuse, and diversion. METHODS: We estab-
lished a multidisciplianry opiate renewal clinic that meets once
a week and sees between 20–50 patients in a group education
setting. A thirty minute educational presentation is made each
session; all patients undergo urine drug testing and blood work.
Patients who are negative for prescribed medication receive a one
week renewal and return date to rule out diversion. Patients who
have street drugs present are referred for Substance abuse coun-
seling and given a one week renewal. Patients who are impaired
do not receive medication and appropriate referral is made.
Patients who are compliant may receive a one month renewal
and face-to-face vists every two months. RESULTS: Unscheduled
walk-in visits decreased by 76%. Referrals for substance abuse
treatment increased by 100%. It was previously difﬁcult to diag-
nose substance abuse without drug testing. Approximately 32%
of patients had positive urine for marijuana, cocaine or both.
CONCLUSIONS: An Opiate renewal clinic for patients with
chronic non-maligant pain and substance abuse can be a cost
effective approach to management.
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OBJECTIVE: Post-herpetic neuralgia (PHN, persistent pain fol-
lowing “shingles”) is common, especially among older persons.
The pain often lasts well beyond the acute episode, occasionally
lasting for several years. This study explored the impact of
chronic pain on perceived health status in patients with PHN.
METHODS: This was a community-based survey where persons
aged ≥65 years with PHN were recruited via advertisements in
24 large US newspapers. Eligible subjects were sent a question-
naire to complete, which included items concerning PHN pain
intensity in the prior week (current, average, worse, least), the
EQ-5D, and a 100-point global health rating scale. RESULTS:
A total of 385 persons participated in the study; 61% were age
≥75 years. Mean (±SD) current, average, worst, and least pain
due to PHN was 4.0 (±2.7), 4.6 (±2.1), 6.0 (±2.4), and 2.9 (±2.3)
respectively. Mean values for the EQ-5D weighted health index
and the global health rating scale were 0.61 (±0.26) and 65.7
(±21.1). There was a strong relationship between pain intensity
and overall health rating. Subjects with “mild” worst pain
(range: 0–4) had a mean health rating of 73.8 (±17.5), while
those with “moderate” (range: 4–<7) or “severe” (range: 7–10)
worst pain had mean values of 65.2 (±21.0) and 60.5 (±22.6)
respectively. Similar results were obtained for other measures of
pain intensity. The EQ-5D weighted health index varied in a
similar fashion in relation to pain intensity. Subjects with “mild”
average pain had a mean EQ-5D weighted health index score of
0.69 (±0.17) while those with “moderate” or “severe” average
pain had mean values of 0.58 (±0.27) and 0.25 (±0.31) respec-
tively. CONCLUSIONS: Pain intensity due to PHN is substan-
tial and has a profound impact on self-reported health.
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OBJECTIVES: Previous literature suggests that increases in the
medical use of opioids over the early 1990s did not contribute
to increased morbidity secondary to opioid abuse. Our objective
was to evaluate the period 1997–2001 to analyze trends in
medical use and medical abuse of three classes of opioid anal-
gesics that are commonly used in sustained-release formulations:
fentanyl, morphine, and oxycodone. METHODS: A retrospec-
tive analysis of the Drug Abuse Warning Network (DAWN) data-
base and the Automation of Reports and Consolidation Order
System (ARCOS) database for the years 1997–2001 was used
for this study. RESULTS: The analysis of the DAWN database
showed that there was an 83.5% increase in all opioid analgesic
mentions from 1997 to 2001. Mentions involving any fentanyl
compound increased 249.8%, any morphine compound
